Sustained Treatment Response after Intravenous Cyclophosphamide in a Patient with Therapy-Resistant COVID-19 Acute Respiratory Distress Syndrome: A Case Report

Treatment of acute respiratory distress syndrome (ARDS) represents a severe complication of coronavirus disease 2019 (COVID-19) infection and is often challenging in intensive care treatment. Potential positive effects of intravenous cyclophosphamide have been reported in interstitial lung diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Haselwanter, Patrick, Bal, Christina, Gompelmann, Daniela, Idzko, Marco, Prosch, Helmut, Zauner, Christian, Schneeweiss-Gleixner, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488024/
https://www.ncbi.nlm.nih.gov/pubmed/37685571
http://dx.doi.org/10.3390/jcm12175506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488024/
https://www.ncbi.nlm.nih.gov/pubmed/37685571
http://dx.doi.org/10.3390/jcm12175506

Ejemplares similares